Skip to content

Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.

A 12-week Randomized, Controlled, Clinical Trial Evaluating the Efficacy of a Dietary Supplement Powder Formula (Daily Ultimate Essentials) in an Adult Population.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06655597
Enrollment
60
Registered
2024-10-23
Start date
2024-10-01
Completion date
2025-06-30
Last updated
2024-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Assessment

Keywords

Dietary Supplement, Healthy Adults

Brief summary

Healthy Adult subjects

Detailed description

The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 12 weeks. The subjects will attend two appointments in the clinic throughout the duration of the study.

Interventions

DIETARY_SUPPLEMENTREDS Powder

Dietary supplement powder

Sponsors

Prenetics Global
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18.5 and 30 kg/m2 * Low, moderate, and high activity (self-identified) \* * Self-identify as having fatigue, and abdominal issues (bloating, constipation etc.) \* * Participants will be able to read, understand and sign an informed consent form (includes HIPAA and States requirements) and sign a photo release form. * Participants are willing and able to follow all study directions, attend study visits as scheduled and must be willing to accept the restrictions of the study including but not limited to: * Willing to refrain from introducing any new diets or dietary supplements for the duration of the study

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Body Morphology12 weeksSubjects assessed through weight and height which will be combined to determine BMI and abdominal and thigh circumference and images before and after

Secondary

MeasureTime frameDescription
Safety and Tolerability12 weeksNumber of participants with treatment-related adverse events as assessed by CTCAE v4.0
Energy12 weeksAssessed by subjective questionnaire
Changes in Micronutrient blood levels12 weeksAssessed through laboratory assays of vitamins and minerals in the blood

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026